Details for New Drug Application (NDA): 202584
✉ Email this page to a colleague
NDA 202584 describes BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE, which is a drug marketed by Nostrum Labs Inc and is included in one NDA. Additional details are available on the BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE profile page.
The generic ingredient in BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE is bismuth subsalicylate; metronidazole; tetracycline hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the bismuth subsalicylate; metronidazole; tetracycline hydrochloride profile page.
The generic ingredient in BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE is bismuth subsalicylate; metronidazole; tetracycline hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the bismuth subsalicylate; metronidazole; tetracycline hydrochloride profile page.
Summary for 202584
| Tradename: | BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE |
| Applicant: | Nostrum Labs Inc |
| Ingredient: | bismuth subsalicylate; metronidazole; tetracycline hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE, TABLET, CAPSULE;ORAL | Strength | 262.4MG, N/A, N/A;N/A, 250MG, N/A;N/A, N/A, 500MG | ||||
| Approval Date: | Nov 30, 2018 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
